Ca Ionophore Vs. Standard Culture Media In Cryopreserved Semen Of Iraqi Patients Undergoing ICSI Cycles
Main Article Content
Keywords
Artificial oocyte activation, in vitro fertilization, intracytoplasmic sperm injection
Abstract
Background: ICSI is increasingly used instead of traditional IVF for all IVF-using couples for several reasons. It has already successfully activated mammalian oocytes with an artificial oocyte activator called calcium ionophores. There is a growing trend to use such activators to address the many covert causes of ineffective fertilization and improve embryo quality. The fear that fertilization might not happen is one of the most important ones.
Aim of the study: to analyze the effects of artificial oocyte activation on the outcomes of ICSI procedure when cryopreserved semen is used.
Material and methods: A total of 17 patients who were selected and subjected to intra-cytoplasmic sperm injection procedure, after controlled ovarian stimulation and ovum pick oocyte immediately following Intracytoplasmic sperm injection were divided into two groups (oocyte with ca ionophore and without ca ionophore) then fertilization rate and embryo quality were checked to each group.
Result: The study involved 162 oocytes, 83 in the ca ionophore group and 79 in the control group. The fertilization rate did not show any noteworthy difference between the two groups. Moreover, there was no significant statistical difference between the two groups regarding embryo grades 1, 2, and 3.
Conclusion: Artificial oocyte activation did not benefit fertilization rate nor embryo quality when cryopreserved semen was used for insemination.
References
2. Cardona Barberán A, Boel A, Vanden Meerschaut F, Stoop D, Heindryckx B. Diagnosis and treatment of male infertility-related fertilization failure. Journal of clinical medicine. 2020;9(12):3899.
3. Borges E, Jr., de Almeida Ferreira Braga DP, de Sousa Bonetti TC, Iaconelli A, Jr., Franco JG, Jr. Artificial oocyte activation with calcium ionophore A23187 in intracytoplasmic sperm injection cycles using surgically retrieved spermatozoa. Fertil Steril. 2009;92(1):131-6.
4. Khan IM, Cao Z, Liu H, Khan A, Rahman SU, Khan MZ, et al. Impact of cryopreservation on spermatozoa freeze-thawed traits and relevance omics to assess sperm cryo-tolerance in farm animals. Frontiers in Veterinary Science. 2021;8:609180.
5. Kashir J, Ganesh D, Jones C, Coward K. Oocyte activation deficiency and assisted oocyte activation: mechanisms, obstacles and prospects for clinical application. Human Reproduction Open. 2022;2022(2):hoac003.
6. Eftekhar M, Janati S, Rahsepar M, Aflatoonian A. Effect of oocyte activation with calcium ionophore on ICSI outcomes in teratospermia: A randomized clinical trial. Iranian Journal of Reproductive Medicine. 2013;11(11):875.
7. Nasr-Esfahani MH, Deemeh MR, Tavalaee M. Artificial oocyte activation and intracytoplasmic sperm injection. Fertility and sterility. 2010;94(2):520-6.
8. Zribi N, Chakroun NF, El Euch H, Gargouri J, Bahloul A, Keskes LA. Effects of cryopreservation on human sperm deoxyribonucleic acid integrity. Fertility and sterility. 2010;93(1):159-66.
9. Borges Jr E, Braga DPdAF, de Sousa Bonetti TC, Iaconelli Jr A, Franco Jr JG. Artificial oocyte activation using calcium ionophore in ICSI cycles with spermatozoa from different sources. Reproductive biomedicine online. 2009;18(1):45-52.
10. Chithiwala ZH, Lee HC, Hill DL, Jellerette-Nolan T, Fissore R, Grow D, et al. Phospholipase C-zeta deficiency as a cause for repetitive oocyte fertilization failure during ovarian stimulation for in vitro fertilization with ICSI: a case report. Journal of assisted reproduction and genetics. 2015;32:1415-9.
11. Ebner T, Köster M, Shebl O, Moser M, Van der Ven H, Tews G, et al. Application of a ready-to-use calcium ionophore increases rates of fertilization and pregnancy in severe male factor infertility. Fertility and sterility. 2012;98(6):1432-7.
12. Karabulut S, Aksünger Ö, Ata C, Sağıroglu Y, Keskin İ. Artificial oocyte activation with calcium ionophore for frozen sperm cycles. Systems Biology in Reproductive Medicine. 2018;64(5):381-8.